At a glance
- The Vision and Eye Health Surveillance System (VEHSS) uses statistical techniques to generate modeled estimates of the prevalence of vision loss and blindness based on multiple data sources included in VEHSS.
- VEHSS also reports prevalence of vision loss and blindness based on data sources available in VEHSS, including survey self-report and objectively measured acuity loss in examination data and the Intelligent Research in Sight (IRIS) Registry.

Overview
Vision loss and blindness includes the following categories:
- Prevalence of Vision Loss, Measured Best Corrected Acuity
- Prevalence of Vision Loss, Measured Presenting Acuity
- Prevalence of Vision Loss, Uncorrected Refractive Error
- Prevalence of Vision Loss, Self-Report
Prevalence of vision loss, measured best corrected acuity
VEHSS reports the prevalence of vision loss based on objectively measured best corrected visual acuity (BCVA) in the better-seeing eye based on VEHSS modeled estimates, the IRIS Registry, and NHANES. BCVA loss, also called uncorrectable vision loss, represents visual acuity deficits measured when using the best available refraction correction: using a refractor, autorefractor, or eyeglasses/contact lenses with optimal prescriptions. The IRIS Registry reports visual acuity among patients of participating ophthalmology practices and thus represents vision loss among a portion of ophthalmology patients.
From 1999-2008 NHANES used autorefractors to approximate BCVA among a nationally representative population sample. VEHSS modeled estimates combine information from multiple sources, including NHANES and national surveys, to produce more comprehensive estimates of the prevalence of BCVA loss. Estimates for measured BCVA include the following subgroups (note: not all data sources include all subgroups).
Subgroup
BCVA in the Better-Seeing Eye
Normal vision
20/12.5 – >20/32
Any vision loss
≤20/32
Mild visual impairment
20/32 – >20/80
Moderate visual impairment
20/80 – >20/200
Visual impairment
20/32 – >20/200
U.S.-defined blindness
≤20/200
World Health Organization (WHO) defined blindness
≤20/400
Monocular Vision Loss
≤20/70 in worse-seeing eye
Missing
Missing acuity data in one or both eyes
Prevalence of vision loss, measured presenting acuity
VEHSS reports the prevalence of vision loss based on objectively measured presenting visual acuity in the better-seeing eye, based on VEHSS modeled estimates, and data from 1999-2008 NHANES and the 2022 National Health and Aging Trends Study (NHATS). Presenting visual acuity loss represents suboptimal visual acuity measured at distance when a person is wearing their usual eyewear, such as eyeglasses or contact lenses. Near-distance acuity indicates the acuity assessments were measured at their normal reading distance, typically about 40 centimeters. Otherwise, results are based on standard distance acuity definitions defined by each data source. Estimates for measured presenting acuity include the following subgroups (note: not all data sources include all subgroups).
Subgroup
Presenting Acuity in the Better-Seeing Eye
Normal vision
20/12.5 – >20/32
Any vision loss
≤20/32
Mild visual impairment
20/32 – >20/80
Moderate visual impairment
20/80 – >20/200
Visual impairment
20/32 – >20/200
U.S.-defined blindness
≤20/200
World Health Organization (WHO) defined blindness
≤20/400
Missing
Missing acuity data in one or both eyes
Prevalence of vision loss, uncorrected refractive error
VEHSS reports the prevalence of uncorrected refractive error (URE) from VEHSS modeled estimates and 1999-2008 NHANES. NHANES measured presenting visual acuity and autorefractor-based BCVA among a nationally representative population sample. URE is defined as the quantity of presenting visual acuity loss that can be corrected with proper refraction.
Subgroup
Definition
Uncorrected Refractive Error
VEHSS modeled estimates: ≤20/40 presenting in the better-seeing eye, improving to >20/40 with correction.
NHANES: ≤20/50 presenting in the better-seeing eye, improving to >20/40 with correction.
Prevalence of vision loss, contrast sensitivity
Contrast sensitivity measures the ability to see subtle differences in shading and patterns or to distinguish objects from their background. Contrast sensitivity is measured based on log contrast sensitivity (logCS). Lower values of logCS indicate worse contrast sensitivity measures. We define normal vision as logCS > 1.55.
Subgroup
Definition
Normal contrast sensitivity
>1.55 logCS
Any contrast sensitivity loss
≤1.55 logCS
Mild contrast sensitivity loss
>1.37 logCS to ≤1.55 logCS
Severe contrast loss
≤1.37 logCS
Prevalence of self-reported vision loss
VEHSS reports the prevalence of vision loss based on self-report from multiple national surveys, including ACS, NSCH, Behavioral Risk Factor Surveillance System (BRFSS), and National Health Interview Survey (NHIS). Self-reported vision loss questions measure perceived vision loss among survey respondents. Self-reported vision loss from surveys can provide large, representative samples that can measure variation by demographic group, risk factors, and geography.
Users should use caution when interpreting self-reported vision loss. VEHSS found high levels of variability between different survey questions and between different surveys, even when asking the same question. A validation study conducted by VEHSS found that, among a sample of ophthalmology/optometry patients, the self-reported survey questions included in VEHSS exhibited only marginally acceptable diagnostic accuracy for predicting BCVA at the person level. However, in this study, population prevalence based on self-report was highly correlated with prevalence based on BCVA among almost all demographic groups. Although additional research is needed, these findings support the assumption that self-reported measures are correlated with objective measures of visual function. Self-reported vision loss may provide accurate representation of trends and of demographic, risk factor, and geographic differences in population visual health, although the prevalence rates and counts may differ from those identified through objective measurement.
Dataset
Description
Question text
Variable Name(s)
Sample
Response Options
ACS
Blind or difficulty seeing even with glasses
Is this person blind or does he/she have serious difficulty seeing even when wearing glasses?
DIFFEYE
All ages
1 – Yes, 2 – No, NA – Not applicable
BRFSS
Blind or difficulty seeing even with glasses
Are you blind or do you have serious difficulty seeing, even when wearing glasses?
BLIND
Ages 18 years or older
1 – Yes, 2 – No, 7 – Don’t know / Not sure, 9 – Refused
NSCH
Blind or difficulty seeing even with glasses (children)
Does this child have any of the following? Blindness or problems with seeing, even when wearing glasses?
BLINDNESS
Ages 0-17 years
1 – Yes, 2 – No
NHIS - Adult module
Percentage of adults who have trouble seeing even when wearing glasses or contact lenses
Do you have difficulty seeing (even when wearing glasses or contact lenses)? Would you say no difficulty, some difficulty, a lot of difficulty, or you cannot do this at all?
VISIONDF_A
Ages 18 years and older
1 – No difficulty, 2 – Some difficulty, 3 – A lot of difficulty, 4 – Cannot do at all, 7 – Refused, 9 – Don’t know
NHIS - Child module
Percentage of children who have difficulty seeing even when wearing glasses or contact lenses
(When wearing glasses (or contact lenses,)) does <child> have difficulty seeing? Would you say <child> has: no difficulty, some difficulty, a lot of difficulty, or cannot do this at all?
VISIONDF_C
Ages 2–17 years
1 – No difficulty, 2 – Some difficulty, 3 – A lot of difficulty, 4 – Cannot do at all, 7 – Refused, 9 – Don’t know
Prevalence of vision loss among people with major eye diseases
VEHSS reports the prevalence of vision loss among people with diagnosed eye disease based on data from the IRIS Registry and NHIS. For both data sources, the prevalence of vision loss was measured among people identified with diagnosed macular degeneration, cataracts, diabetic retinopathy, and glaucoma. In NHIS, respondents were asked if they had a diagnosed eye disease, and those who responded in the affirmative were asked if this had caused vision loss. In the IRIS Registry, disease diagnoses are based on ICD-10 diagnosis codes and vision loss is based on best corrected visual acuity. While the NHIS questions may indicate causality of vision loss, the IRIS Registry results represent the prevalence of vision loss from any cause among persons with one or more eye diseases.
Self-reported vision loss due to eye disease
Dataset
Description
Question Text
Variable Name(s)
Sample
Response Options
NHIS – Adult module
Percentage of people with diagnosed macular degeneration who report losing vision due to macular degeneration
Have you lost any vision due to macular degeneration?
VIMLSMD_A
Ages 45 years and older with macular degeneration
1 – Yes, 2 – No, 7 – Refused, 9 – Don’t know
NHIS – Adult module
Percentage of people with diagnosed cataract who report losing vision due to cataracts
Have you lost any vision due to cataracts?
VIMLSCA_A
Ages 45 years and older with cataracts
1 – Yes, 2 – No, 7 – Refused, 9 – Don’t know
NHIS – Adult module
Percentage of people with diagnosed diabetic retinopathy who report losing vision due to diabetic retinopathy
Have you lost any vision due to diabetic retinopathy?
VIMLSDR_A
Ages 18 years and older with diabetic retinopathy
1 – Yes, 2 – No, 7 – Refused, 9 – Don’t know
NHIS – Adult module
Percentage of people with diagnosed glaucoma who report losing vision due to glaucoma
Have you lost any vision due to glaucoma?
VIMLSGL_A
Ages 18 years and older with glaucoma
1 – Yes, 2 – No, 7 – Refused, 9 – Don’t know
Best corrected visual acuity loss among people diagnosed with eye disease
| Acuity Category | Best Corrected Acuity | Risk Factor |
|---|---|---|
| Normal vision | 20/12.5 – >20/32 | AMD, cataract, diabetic retinopathy, glaucoma |
| Any vision loss | ≤20/32 | AMD, cataract, diabetic retinopathy, glaucoma |
| Mild visual impairment | 20/32 – >20/80 | AMD, cataract, diabetic retinopathy, glaucoma |
| Moderate visual impairment | 20/80 – >20/200 | AMD, cataract, diabetic retinopathy, glaucoma |
| Visual impairment | 20/32 – >20/200 | AMD, cataract, diabetic retinopathy, glaucoma |
| U.S.-defined blindness | ≤20/200 | AMD, cataract, diabetic retinopathy, glaucoma |
| World Health Organization (WHO) defined blindness | ≤20/400 | AMD, cataract, diabetic retinopathy, glaucoma |
| Missing | Missing acuity data in one or both eyes | AMD, cataract, diabetic retinopathy, glaucoma |
This page was last updated on this date. Updates may include minor edits, image changes, or other modifications to page content.
The information on this page was last reviewed by subject matter experts to ensure accuracy.